Differences between national and international guidelines for the management of diabetic foot disease

No studies have investigated if national guidelines to manage diabetic foot disease differ from international guidelines. This study aimed to compare guidelines of Western Pacific nations with the International Working Group on the Diabetic Foot (IWGDF) guidance documents.

[1]  Jane E. A. Lewis,et al.  Pressure-relieving interventions for treating diabetic foot ulcers. , 2013, The Cochrane database of systematic reviews.

[2]  H. Vermeulen,et al.  Topical silver for treating infected wounds. , 2007, The Cochrane database of systematic reviews.

[3]  J. Rauwerda,et al.  Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000. , 2004, Diabetes care.

[4]  J. Llobera,et al.  Treatment of chronic diabetic foot ulcers with bemiparin: a randomized, triple‐blind, placebo‐controlled, clinical trial , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[5]  Benjamin A Lipsky,et al.  IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes , 2016, Diabetes/metabolism research and reviews.

[6]  T. Vos,et al.  US Spending on Personal Health Care and Public Health, 1996-2013. , 2016, JAMA.

[7]  G. King,et al.  Vascular complications of diabetes: mechanisms of injury and protective factors. , 2013, Cell metabolism.

[8]  Khorshid,et al.  Clinical application of oral form of ANGIPARS TM and in combination with topical form as a new treatment for diabetic foot ulcers : A randomized clinical trial , 2008 .

[9]  A. Vinik,et al.  Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. , 2004, Diabetes care.

[10]  Ya-Ju Yang,et al.  Treatment of diabetic foot ulcers: a comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. , 2011, Diabetes research and clinical practice.

[11]  Sicco A Bus,et al.  Diabetic Foot Ulcers and Their Recurrence. , 2017, The New England journal of medicine.

[12]  Farhadi,et al.  Effects of intravenous Semelil (ANGIPARSTM) on diabetic foot ulcers healing: A multicenter clinical trial , 2008 .

[13]  David T. Mauger,et al.  Prevention of Recurrent Foot Ulcers With Plantar Pressure–Based In-Shoe Orthoses: The CareFUL Prevention Multicenter Randomized Controlled Trial , 2014, Diabetes Care.

[14]  S. Mukhopadhyay,et al.  A Comparative Study Between Total Contact Cast and Pressure-Relieving Ankle Foot Orthosis in Diabetic Neuropathic Foot Ulcers , 2014, Journal of diabetes science and technology.

[15]  A. Basit,et al.  Use of locally made off‐loading techniques for diabetic plantar foot ulcer in Karachi, Pakistan , 2014, International wound journal.

[16]  D. Armstrong,et al.  Diabetes‐related lower‐extremity complications are a leading cause of the global burden of disability , 2018, Diabetic medicine : a journal of the British Diabetic Association.

[17]  P. Leung,et al.  Limb salvage in extensive diabetic foot ulceration: an extended study using a herbal supplement. , 2008, Hong Kong medical journal = Xianggang yi xue za zhi.

[18]  T. Merlin,et al.  Comparison of the clinical effectiveness of different off‐loading devices for the treatment of neuropathic foot ulcers in patients with diabetes: a systematic review and meta‐analysis , 2013, Diabetes/metabolism research and reviews.

[19]  G. Rayman,et al.  Reduction in Diabetic Amputations Over 11 Years in a Defined U.K. Population , 2008, Diabetes Care.

[20]  K. Shankhdhar,et al.  Instant Offloading of a Diabetic Foot Ulcer , 2016 .

[21]  G. Seghieri,et al.  Improvement of diabetic foot care after the Implementation of the International Consensus on the Diabetic Foot (ICDF): results of a 5-year prospective study. , 2007, Diabetes research and clinical practice.

[22]  S. Bus,et al.  Prevention of foot ulcers in the at‐risk patient with diabetes: a systematic review , 2016, Diabetes/metabolism research and reviews.

[23]  S. Bus,et al.  IWGDF guidance on the prevention of foot ulcers in at‐risk patients with diabetes , 2016, Diabetes/metabolism research and reviews.

[24]  Ashutosh Kumar Singh,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[25]  S. Porramatikul,et al.  Changing the patterns of hospitalized diabetic foot ulcer (DFU) over a 5-year period in a multi-disciplinary setting in Thailand , 2020, BMC Endocrine Disorders.

[26]  David G. Armstrong,et al.  Mind the Gap: Disparity Between Research Funding and Costs of Care for Diabetic Foot Ulcers , 2013, Diabetes Care.

[27]  C. Attinger,et al.  IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes , 2016, Diabetes/metabolism research and reviews.

[28]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[29]  F. Bowling,et al.  The role of foot pressure measurement in the prediction and prevention of diabetic foot ulceration—A comprehensive review , 2019, Diabetes/metabolism research and reviews.

[30]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[31]  M. Saghari,et al.  Clinical application of oral form of ANGIPARS™ and in combination with topical form as a new treatment for diabetic foot ulcers: A randomized clinical trial , 2008 .

[32]  David G Armstrong,et al.  The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). , 2014, Journal of vascular surgery.

[33]  M. Cowie.  National Institute for Health and Care Excellence. , 2015, European heart journal.

[34]  D. Armstrong,et al.  IWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes , 2016, Diabetes/metabolism research and reviews.

[35]  Sicco A. Bus,et al.  Effect of Custom-Made Footwear on Foot Ulcer Recurrence in Diabetes , 2013, Diabetes Care.

[36]  Quality Standards for Diabetes Care Toolkit , 2014 .

[37]  M. Spraul,et al.  Prospective randomized controlled study of Hydrofiber® dressing containing ionic silver or calcium alginate dressings in non‐ischaemic diabetic foot ulcers , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[38]  Benjamin A Lipsky,et al.  Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents , 2016, Diabetes/metabolism research and reviews.

[39]  M. Rahman,et al.  Neuropharmacological effects of Peperomia pellucida leaves in mice , 2008 .

[40]  A. Younger,et al.  Outcome of Transmetatarsal Amputations in Diabetics Using Antibiotic Beads , 2009, Foot & ankle international.

[41]  N. Ullah,et al.  COMPARISON OF CONVENTIONAL PYODINE DRESSING WITH HONEY DRESSING FOR THE TREATMENT OF DIABETIC FOOT ULCERS , 2012 .

[42]  K. Aikimbaev,et al.  Effects of iloprost (a prostacyclin analogue) on the endothelial dysfunction and foot ulcers in diabetic patients with peripheral arterial disease , 2008 .

[43]  Anthony W. Russell,et al.  Reduced Incidence of Foot-Related Hospitalisation and Amputation amongst Persons with Diabetes in Queensland, Australia , 2015, PloS one.

[44]  Wang Jin,et al.  A New Automatic Foot Arch Index Measurement Method Based on a Flexible Membrane Pressure Sensor. , 2020 .

[45]  D. Jupiter,et al.  The impact of foot ulceration and amputation on mortality in diabetic patients. I: From ulceration to death, a systematic review , 2016, International wound journal.

[46]  W. Jeffcoate,et al.  Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes. , 2009, Health technology assessment.

[47]  Lloyd Reed,et al.  Direct inpatient burden caused by foot-related conditions: a multisite point-prevalence study , 2016, BMJ Open.

[48]  Dalong Zhu,et al.  Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis† , 2017, Annals of medicine.

[49]  M. Reed,et al.  Scottish Intercollegiate Guidelines Network (SIGN) 84 -- National Clinical Guideline for the Management of Breast Cancer in Women. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[50]  Benjamin A Lipsky,et al.  The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence‐based global consensus , 2016, Diabetes/metabolism research and reviews.

[51]  J. Reekers,et al.  IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes , 2016, Diabetes/metabolism research and reviews.

[52]  S. Wild,et al.  Reduced Incidence of Lower-Extremity Amputations in People With Diabetes in Scotland , 2012, Diabetes Care.

[53]  A. Boulton,et al.  The global burden of diabetic foot disease , 2005, The Lancet.

[54]  A. R. Sulaiman,et al.  A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. , 2008, The Medical journal of Malaysia.